The platform can work via a connectivity module with any Stellar or Astral ventilator in Europe, and Lumis bilevel devices have a built-in AirView connection. With AirView, clinicians can remotely monitor their patients’ respiratory rate and blood oxygen saturation to track changes in their condition, enabling remote care for long-term ventilator users.
We have leveraged our cloud-connected technology which we have developed in our sleep apnoea solutions and built upon it to assist healthcare professionals in their care provision to ventilated patients. How does the cloud-connected technology work in relation to ventilators and what has the effect been during COVID-19? Recently, the insights and benefits of AirView for sleep therapy have been applied to ventilated patients this has been launched as AirView for Ventilation, which is one of our most recent initiatives in respiratory care services. This is made possible by ResMed’s sleep and respiratory care devices’ built-in wireless connectivity that transmits data and therapy statistics from devices enabled with myAir to AirView which displays the information in reader-friendly graphics. While the devices we develop at ResMed have auto-adjusting features with algorithms that allow for additional customisation of sleep apnoea therapy, AirView also allows physicians to troubleshoot devices or change device settings remotely. Described briefly, AirView is a securely hosted, cloud-based platform that serves as a patient management system and allows healthcare providers to remotely track patients’ progress and quickly identify and resolve issues. This software is complemented by technology designed for healthcare professionals-AirView-which, when used in conjunction with myAir, boosts patient compliance by 87%. Research shows that patients using the myAir software platform significantly improve in their daily CPAP usage and adherence to sleep therapy. The technology it employs empowers patients to track and understand their therapy, receive daily and periodical reports, and consult educational and self-help tools and videos for additional support. myAir is designed to motivate patients by tracking their sleep data and coaching them through a personalised programme tailored to their specific needs and sleep patterns. ResMed’s innovative technology that underlies its software platforms benefits patients, as well as healthcare professionals. Tell us about the technology behind the devices. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for our healthcare systems.
These platforms allow remote monitoring and effective management of symptoms and conditions which can be responded to in real time, without the need for in-person appointments or prolonged stays in hospital. Utilising cloud-connected technology and enabling remote care pathways help to relieve pressure on care systems through software platforms. Our devices went digital in 2014, optimising our offering and giving greater freedom and flexibility to patients and caregivers alike. Fast forward eight years, Dr Peter Farrell founded ResMed and bought Sullivan’s sleep technology, commercialising his prototype CPAP device and bringing the device to the mainstream market, which led to ResMed as we know it today. Our story begins in 1981, when Professor Colin Sullivan and colleagues at the University of Sydney developed Continuous Positive Airway Pressure (CPAP), a successful non-invasive treatment for obstructive sleep apnoea (OSA).
0 kommentar(er)
